sponsored
PatientsVille.com Logo

PatientsVille

Mirtazapine and Oxycodone

Compare Side Effects

% of total side effects reported by users. DISCLAIMER: ALL DATA PROVIDED AS-IS. Data Source: openfda.gov.
Side EffectMirtazapineOxycodone
DEATH1.7% 8.9%
TOXICITY TO VARIOUS AGENTS2.4% 7.3%
OVERDOSE1.5% 4.1%
NAUSEA2.5% 3.1%
FATIGUE2.2% 2.5%
DRUG INEFFECTIVE2.1% 2.5%
PAIN1.5% 2.5%
DRUG INTERACTION2.4% 0.6%
DRUG ABUSE1.2% 2.3%
COMPLETED SUICIDE2.1% 1.4%
FALL2.1% 1.4%
DIARRHOEA2% 2%
VOMITING1.8% 2%
ANXIETY2% 1.1%
DEPRESSION2% 1%
CONFUSIONAL STATE2% 0.9%
DIZZINESS1.9% 1.3%
DYSPNOEA1.8% 1.8%
HEADACHE1.7% 1.6%
MALAISE1.7% 1.3%
INSOMNIA1.6% 1%
SOMNOLENCE1.6% 0.9%
ASTHENIA1.5% 1.4%
TREMOR1.5% 0.6%
PNEUMONIA1.2% 1.4%
SUICIDAL IDEATION1.4% 0%
AGITATION1.3% 0%
PYREXIA1.1% 1.2%
ARTHRALGIA1% 1.2%
CONSTIPATION0.9% 1.2%
HYPOTENSION1.2% 0.8%
BACK PAIN0.7% 1.2%
CONDITION AGGRAVATED1.2% 0.6%
SUICIDE ATTEMPT1.2% 0%
WEIGHT DECREASED1.1% 1.1%
DECREASED APPETITE1.1% 1%
OFF LABEL USE1.1% 0.9%
PAIN IN EXTREMITY0.9% 1.1%
ABDOMINAL PAIN0.8% 1%
WEIGHT INCREASED1% 0.6%
HYPERHIDROSIS1% 0.6%
LOSS OF CONSCIOUSNESS1% 0.5%
HYPONATRAEMIA1% 0%
CARDIAC ARREST0.8% 0.9%
RASH0.7% 0.9%
GAIT DISTURBANCE0.9% 0.7%
DRUG DEPENDENCE0% 0.9%
INTENTIONAL OVERDOSE0.9% 0%
TACHYCARDIA0.9% 0%
SEROTONIN SYNDROME0.9% 0%
DEHYDRATION0.8% 0.8%
FEELING ABNORMAL0.8% 0.8%
ANAEMIA0.7% 0.8%
HYPERTENSION0.8% 0.6%
URINARY TRACT INFECTION0.8% 0.6%
MUSCLE SPASMS0.8% 0.6%
CHEST PAIN0.6% 0.8%
PARAESTHESIA0.8% 0.5%
AGGRESSION0.8% 0%
RESPIRATORY ARREST0% 0.8%
CARDIO-RESPIRATORY ARREST0% 0.8%
OEDEMA PERIPHERAL0.7% 0.7%
PRURITUS0.6% 0.7%
MYALGIA0.7% 0.5%
ACUTE KIDNEY INJURY0.7% 0.5%
DRUG DOSE OMISSION0.5% 0.7%
DYSPHAGIA0.7% 0.4%
HALLUCINATION0.7% 0%
SYNCOPE0.7% 0%
ACCIDENTAL OVERDOSE0% 0.7%
ELECTROCARDIOGRAM QT PROLONGED0.7% 0%
HYPOAESTHESIA0.6% 0.6%
MEMORY IMPAIRMENT0.6% 0.5%
ABDOMINAL PAIN UPPER0.5% 0.6%
COUGH0.5% 0.6%
MALIGNANT NEOPLASM PROGRESSION0% 0.6%
DRUG WITHDRAWAL SYNDROME NEONATAL0% 0.6%
DRUG HYPERSENSITIVITY0% 0.6%
RESTLESSNESS0.6% 0%
PALPITATIONS0.6% 0%
SEIZURE0.6% 0%
DELIRIUM0.6% 0%
SLEEP DISORDER0.6% 0%
CONVULSION0.6% 0%
DRUG WITHDRAWAL SYNDROME0.5% 0.5%
SEPSIS0.5% 0.5%
RENAL FAILURE0.5% 0.5%
PULMONARY EMBOLISM0.5% 0.5%
HAEMOGLOBIN DECREASED0.5% 0.5%
CEREBROVASCULAR ACCIDENT0.5% 0.4%
VISION BLURRED0.5% 0.4%
RHABDOMYOLYSIS0.5% 0%
DISEASE PROGRESSION0% 0.5%
NEUROPATHY PERIPHERAL0% 0.5%
PERIPHERAL SWELLING0% 0.5%
ABDOMINAL DISCOMFORT0% 0.5%
DEEP VEIN THROMBOSIS0% 0.5%
DYSKINESIA0.5% 0%
COMA0.5% 0%
DYSARTHRIA0.5% 0%
RESTLESS LEGS SYNDROME0.5% 0%
WITHDRAWAL SYNDROME0.5% 0%
GENERAL PHYSICAL HEALTH DETERIORATION0.5% 0%
SOPOR0.5% 0%
NIGHTMARE0.5% 0%
DEPRESSED MOOD0.5% 0%
DISTURBANCE IN ATTENTION0.5% 0%
DIABETES MELLITUS0.5% 0%
BALANCE DISORDER0.5% 0%
ALANINE AMINOTRANSFERASE INCREASED0.5% 0%
DISORIENTATION0.5% 0%
PSYCHOTIC DISORDER0.5% 0%
RESPIRATORY FAILURE0% 0.4%
ERYTHEMA0% 0.4%
CONTUSION0% 0.4%
DRUG EFFECT DECREASED0% 0.4%
GASTROINTESTINAL HAEMORRHAGE0% 0.4%
MENTAL STATUS CHANGES0% 0.4%
THROMBOCYTOPENIA0% 0.4%
INFECTION0% 0.4%
MUSCULAR WEAKNESS0% 0.4%
ALOPECIA0% 0.4%
PLEURAL EFFUSION0% 0.4%
WHITE BLOOD CELL COUNT DECREASED0% 0.4%
PLATELET COUNT DECREASED0% 0.4%
MYOCARDIAL INFARCTION0% 0.4%
BLOOD PRESSURE INCREASED0% 0.4%
CHILLS0% 0.4%
PRODUCT QUALITY ISSUE0% 0.4%
INTENTIONAL PRODUCT MISUSE0% 0.4%
BLOOD GLUCOSE INCREASED0% 0.3%
ATRIAL FIBRILLATION0% 0.3%
NEUTROPENIA0% 0.3%

New treatments are found every day. View current Mirtazapine research studies and Oxycodone clinical trials

1